Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision

被引：6

作者：

Mackintosh, John A. ^{[1
,2
]}

Keir, Gregory ^{[3
]}

Troy, Lauren K. ^{[4
,5
]}

Holland, Anne E. ^{[2
,6
,7
]}

Grainge, Christopher ^{[8
]}

Chambers, Daniel C. ^{[1
,2
]}

Sandford, Debra ^{[2
,9
,10
]}

Jo, Helen E. ^{[4
,5
]}

Glaspole, Ian ^{[2
,11
]}

Wilsher, Margaret ^{[12
]}

Goh, Nicole S. L. ^{[13
,14
,15
]}

Reynolds, Paul N. ^{[2
,9
,10
]}

Chapman, Sally ^{[16
]}

Mutsaers, Steven E. ^{[17
]}

de Boer, Sally ^{[12
]}

Webster, Susanne ^{[4
]}

Moodley, Yuben ^{[2
,16
,17
]}

Corte, Tamera J. ^{[2
,4
,5
]}

机构：

[1] Prince Charles Hosp, Dept Resp Med, Brisbane, Qld 4035, Australia

[2] Ctr Res Excellence Pulm Fibrosis, Camperdown, NSW, Australia

[3] Princess Alexandra Hosp, Dept Resp Med, Brisbane, Qld, Australia

[4] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Camperdown, NSW, Australia

[5] Univ Sydney, Sydney, NSW, Australia

[6] Alfred Hosp, Dept Physiotherapy, Melbourne, Vic, Australia

[7] Monash Univ, Cent Clin Sch, Dept Resp Res Alfred, Melbourne, Vic, Australia

[8] John Hunter Hosp, Dept Resp Med, Newcastle, NSW, Australia

[9] Cent Adelaide Local Hlth Network, Dept Thorac Med, Adelaide, SA, Australia

[10] Univ Adelaide, Adelaide, SA, Australia

[11] Alfred Hosp, Dept Resp Med, Melbourne, Vic, Australia

[12] Te Toka Tumai Auckland, Dept Resp Med, Auckland, New Zealand

[13] Austin Hosp, Dept Resp Med, Melbourne, Vic, Australia

[14] Inst Breathing & Sleep, Melbourne, Vic, Australia

[15] Univ Melbourne, Melbourne, Vic, Australia

[16] Univ Western Australia, Inst Resp Hlth, Nedlands, WA, Australia

[17] Fiona Stanley Hosp, Dept Resp Med, Murdoch, WA, Australia

来源：

RESPIROLOGY | 2024年 / 29卷 / 02期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

idiopathic pulmonary fibrosis; interstitial lung disease; progressive pulmonary fibrosis; pulmonary fibrosis; treatment; INTERSTITIAL LUNG-DISEASE; OBSTRUCTIVE SLEEP-APNEA; QUALITY-OF-LIFE; PALLIATIVE CARE; ACUTE EXACERBATION; DOUBLE-BLIND; INTERNATIONAL SOCIETY; GASTROESOPHAGEAL-REFLUX; TELOMERE LENGTH; CLINICAL CHARACTERISTICS;

D O I：

10.1111/resp.14656

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.

引用

页码：105 / 135

页数：31

共 50 条

[21] Treatment of idiopathic pulmonary fibrosis
Daniels, Craig E.
Ryu, Jay H.
[J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) : 668 - 676
[22] Treatment of idiopathic pulmonary fibrosis
Valeyre, Dominique
Dion, Genevieve
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (02): : 367 - 381
[23] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
NICOD, LP
[J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 125 (10) : 483 - 488
[24] Treatment of Idiopathic Pulmonary Fibrosis
Abuserewa, Sherif T.
Duff, Richard
Becker, Gregory
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
[25] THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
WINTERBAUER, RH
[J]. CHEST, 1991, 100 (01) : 233 - 235
[26] Treatment of Idiopathic Pulmonary Fibrosis
Carlos, William G.
Strek, Mary E.
Wang, Tisha S.
Patel, Harin
Raghu, Ganesh
Wilson, Kevin C.
Thomson, Carey C.
[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 115 - 117
[27] A NEW ANIMAL-MODEL OF PROGRESSIVE IDIOPATHIC PULMONARY FIBROSIS
LAST, JA
GELZLEICHTER, T
HAWK, S
PINKERTON, K
WITSCHI, H
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A596 - A596
[28] 2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
Tzilas, Vasilios
Tzouvelekis, Argyrios
Ryu, Jay H.
Bouros, Demosthenes
[J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : 729 - 731
[29] POSITION STATEMENT OF THE THORACIC SOCIETY OF AUSTRALIA AND NEW-ZEALAND ON SMOKERS COMPENSATION
MUSK, AW
SHEAN, R
WALKER, N
[J]. AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1994, 18 (03): : 345 - 345
[30] Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
Alvarez, Diana
Levine, Melanie
Rojas, Mauricio
[J]. STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2015, 8 : 61 - 65

← 1 2 3 4 5 →